Feasibility and safety of oupatient Bexxar® therapy (tositumomab and iodine I 131 tositumomab) for Non-Hodgkin’s lymphoma based on radiation doses to family members

Frank J. Rutar, Samuel C. Augustine, Mark S. Kaminski, Richard L. Wahl, Jeffry A. Siegel, David Colcher

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint Dive into the research topics of 'Feasibility and safety of oupatient Bexxar® therapy (tositumomab and iodine I 131 tositumomab) for Non-Hodgkin’s lymphoma based on radiation doses to family members'. Together they form a unique fingerprint.

Medicine & Life Sciences